We and others have shown that increased MYCN protein stability is acquired by neuroblastoma cells, even in the presence of MYCN amplification, by multiple feed-forward expression loops involving MYCN trans-activation and -repression target genes [6–8]. The gene discussed is MYCN; the disease is neuroblastoma.